PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial CancersLeisl Packer, Pamela M. Pollock|Molecular Cancer Therapeutics|2017Cited by 51
Bcl‐2 inhibitors enhance <scp>FGFR</scp> inhibitor‐induced mitochondrial‐dependent cell death in FGFR2‐mutant endometrial cancerLeisl Packer, Pamela M. Pollock|Molecular Oncology|2018Cited by 22